Stocktoria

GRAIL, Inc. GRAL

Nasdaq · stock · Services-Medical Laboratories · website · IPO 2024-06-12 · LEI

GRAIL, Inc. statistics & valuation

Market cap$2.8B
P / S19.2×
P / B1.1×
Net margin-277.5%
Return on equity-15.8%
FCF margin-203.8%
Return on capital-19.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-1574.20% -1613.90% -277.50% 202320242025
Gross margin (%)
202320242025
Operating margin (%)
-1627.60% -1743.00% -382.00% 202320242025
Return on equity (%)
-81.00% -15.80% 202320242025
Shares outstanding
31.0M 33.9M 40.3M 202320242025
Net debt ($)
202320242025
Share buybacks ($)
202320242025
Return on assets (%)
-37.40% -67.90% -14.00% 202320242025
Free cash flow margin (%)
-653.80% -463.70% -203.80% 202320242025
Debt / equity (×)
202320242025
EPS ($)
-$47.21 -$63.54 -$11.11 202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023
Operating margin-382.0%-1743.0%-1627.6%
Net margin-277.5%-1613.9%-1574.2%
FCF margin-203.8%-463.7%-653.8%
Return on assets-14.0%-67.9%-37.4%
Return on equity-15.8%-81.0%—
Current ratio11.9710.660.95

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.